Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic

BACKGROUND AND OBJECTIVES: Cebranopadol is a novel first-in-class analgesic acting as a nociceptin/orphanin FQ peptide and opioid peptide receptor agonist with central analgesic activity. It is currently in clinical development for the treatment of chronic pain conditions. This trial focuses on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleideiter, Elke, Piana, Chiara, Wang, Shaonan, Nemeth, Robert, Gautrois, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766727/
https://www.ncbi.nlm.nih.gov/pubmed/28623508
http://dx.doi.org/10.1007/s40262-017-0545-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766727/
https://www.ncbi.nlm.nih.gov/pubmed/28623508
http://dx.doi.org/10.1007/s40262-017-0545-1

Ejemplares similares